Development of matrix-membrane transdermal drug delivery system for Atenolol

Drug Delivery: Journal of Delivery and Targeting of Therapeutic Agents

Volumn 11, Issue 5, 2004, Pages 281-286

  Gupta, S P ^a   Jain, S K ^b  

^a GOVERNMENT COLLEGE OF PHARMACY   (India)

^b DR H S GOUR UNIVERSITY   (India)

Author keywords

Atenolol; Eudragits RL; Matrix Diffusion Controlled Transdermal Delivery System; Polyethylene Glycol 4000; Polyvinyl Pyrrolidone

Indexed keywords

ADHESIVE AGENT; ATENOLOL; ATPARK; EUDRAGIT; MACROGOL 4000; POLYMER; POVIDONE;

ANIMAL TISSUE; ARTICLE; ARTIFICIAL MEMBRANE; CONTROLLED DRUG RELEASE; CONTROLLED RELEASE FORMULATION; DRUG DELIVERY SYSTEM; DRUG DETERMINATION; DRUG PENETRATION; FEMALE; IN VITRO STUDY; IN VIVO STUDY; MALE; MATRIX DIFFUSION CONTROLLED TRANSDERMAL DRUG DELIVERY SYSTEM; MATRIX MEMBRANE; NEWBORN; NONHUMAN; PERFORMANCE; PRIORITY JOURNAL; RABBIT; SKIN IRRITATION; SKIN PENETRATION; SUSTAINED RELEASE PREPARATION; SWINE; TENSILE STRENGTH; THICKNESS; TRANSDERMAL DRUG ADMINISTRATION;

ADMINISTRATION, CUTANEOUS; ADMINISTRATION, ORAL; ADRENERGIC BETA-ANTAGONISTS; ANIMALS; AREA UNDER CURVE; ATENOLOL; DELAYED-ACTION PREPARATIONS; DRUG DELIVERY SYSTEMS; DRUG EVALUATION, PRECLINICAL; FEMALE; MALE; POLYETHYLENE GLYCOLS; POLYMERS; POVIDONE; RABBITS; SKIN; SKIN ABSORPTION; SWINE; TECHNOLOGY, PHARMACEUTICAL; TENSILE STRENGTH; TIME FACTORS;

EID: 4944265465     PISSN: 10717544     EISSN: None     Source Type: Journal    
DOI: 10.1080/10717540490493943     Document Type: Article

References (19)

1. Bondor, N., Zupan, J., and Selk, S. 1980. Improved delivery through biological membrane. VIII. Dermal delivery of cromoglycic acid (Cromolyn) via its prodrug. Int. J. Pharm. 7:63-75.
2. Brazel, S. C., and Huang, X. 2001. On the importance and mechanisms of burst release in matrix-controlled drug delivery systems. J. Cont. Rel. 73:121-136.
3. Chien, W. Y. 1984. Pharmaceutical considerations of transdermal nitroglycerin delivery: the various approaches. Am. Heart J. 108:207-216.
4. Corbo, M., Liu, J. C., and Chien, Y. W. 1990. Bioavailability of propranolol following oral and transdermal administration in rabbits. J. Pharm. Sci. 79:584-587.
5. Fitzpatrick, J. B., Eisen, A. Z., Wolf, K., Freedberg, I. M., and Austin, K. F. 1993. Dermatology in General Medicine. New York: MacGraw Hill, Co., Inc.
6. Good, R. W. 1983. Transdrem-nitro controlled delivery of nitroglycerin via the transdermal route. Drug Dev. Ind. Pharm. 9:647-670.
7. Haung, C. Y., Keshary, P. R., and Chien, Y. W. 1985. Improvement in transdermal bioavailability of nitroglycerin by formulation design. Drug Dev. Ind. Pharm. 11:1255-1270.
8. Iyer, V. B., and Vasavada, R. G. 1979. Evaluation of lanolin alcohol films and kinetics of triamcinolone acetonide release. J. Pharm. Sci. 68:783-785.
9. Jain, G. K., Kaul, J. L., and Agrawal, S. S. 1993. In vitro transdermal delivery of atenolol using mouse and guinea pig. Indian J. Exp. Biol. 31:691-693.
10. Paget, G. E., and Barnes, M. J. 1964. Evaluation of drug activities. In Pharmacometrices, ed. R. D. Lawrence and L. A. Bacharach, 155-156. New York: Academic Press.
11. Rao, R. P., Ramakrishna, S., and Diwan, P. V. 2000. Drug release kinetics from polymeric films containing propranolol hydrochloride for transdermal use. Pharm. Dev. Tech. 5:465-472.
12. Seth, A. K., Agrawal, G. P., and Saini, T. R. 1985. Evaluation of free films. Indian Drugs 23:45-47.
13. Siddiqui, O., Sun, Y., Liu, J. C., and Chien, Y. W. 1987. Facilitated transdermal transport of insulin. J. Pharm. Sci. 76:341-345.
14. Shaw, E. J., and Chandrasekaran, S. K. 1978. Controlled topical delivery of drug for systemic action. Drug Metab. Rev. 8:223-233.
15. Tracqui, A., Kintz, P., and Mangin, P. 1995. Systematic toxicological analysis using HPLC DAD. J. Forensic Sci. 40:254-262.
16. Umprayn, K., and Opanasopit, P. 2000. Development of a matrix-membrane transdermal delivery system for nicotine. Pharm. Tech. Asia. Sept/Oct: 15-20.
17. Vyas, P. S., Jain, C. P., Gupta, S., and Uppadhayay, A. 1994. Polymeric pseudolatices dispersion bearing isosorbide dinitrate for transdermal application. Drug Dev. Ind. Pharm. 20:101-110.
18. Wilkinson, J. B., and Moore, R. J. 1989. Harry's Cosmeticology. Longman Scientific and technical England: 38-39.
19. Zhao, H., Park, D. W., Kim, S. K., Lee, C. H., and Kim, D. D. 2002. The effects of pressure-sensitive adhesives and solubilizers on the skin pemeation of testosterone from matrix-type transdermal delivery system. Drug Dev. Ind. Pharm. 28:1125-1131.